Skip to main content
logo
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.06
+0.19 (3.90%)
Aug 27, 2026, 9:18 AM EDT - Market open

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1191219610712-
Market Cap Growth
3.45%26.77%-10.29%769.50%--
Enterprise Value
7693659624-
Last Close Price
4.875.805.737.414.74-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.2515.2726.9417.78--
PB Ratio
2.642.822.422.99-1.46-
P/TBV Ratio
2.642.822.422.99--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.8611.7318.2015.97--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----1.54-
Net Debt / Equity Ratio
-1.00-1.09-0.97-0.92-0.84-1.19
Net Debt / EBITDA Ratio
2.072.312.234.45-0.760.89
Net Debt / FCF Ratio
2.754.363.732.92-0.971.07
Asset Turnover
0.200.170.080.24--
Quick Ratio
12.297.9710.227.941.553.78
Current Ratio
13.408.5111.598.151.883.99
Return on Equity (ROE)
-60.54%-51.39%-39.57%-58.64%--81.90%
Return on Assets (ROA)
-32.27%-26.86%-25.15%-18.53%-88.03%-44.96%
Return on Capital Employed (ROCE)
-47.60%-46.00%-42.50%-20.30%-203.10%-133.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.97%-17.49%-15.54%-7.49%-99.77%-
FCF Yield
-13.76%-8.85%-10.75%-10.48%-58.99%-
Buyback Yield / Dilution
-22.38%-9.79%-49.93%-292.40%-0.01%-40.88%
SEC Filings: 10-K · 10-Q